Brincidofovir inhibits polyomavirus infection in vivo .

Arrienne B ButicZoe E KatzGe JinKoji FukushimaMasatoshi HazamaAron E Lukacher Matthew D Lauver

Published in: mBio (2024)

using mouse polyomavirus. We show that the drug is well-tolerated in mice, reduces infectious viral titers, and limits viral pathology, indicating the potential of brincidofovir as an anti-polyomavirus therapeutic.

Keyphrases

sars cov
high fat diet induced
type diabetes
metabolic syndrome
risk assessment
skeletal muscle
adverse drug